Saba Capital Management’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Saba Capital Management’s Portfolio XAGE Stock Details XAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,278	Closed	-$1.32M	–	594
2023 Q2	$1.32M	Sell	4,278 -4,055	-49%	-$1.24M	0.03%	259
2023 Q1	$2.54M	Hold	8,333	–	–	0.05%	312
2022 Q4	$2.48M	Hold	8,333	–	–	0.03%	475
2022 Q3	$2.43M	Hold	8,333	–	–	0.03%	614
2022 Q2	$2.42M	Hold	8,333	–	–	0.03%	642
2022 Q1	$2.44M	Hold	8,333	–	–	0.03%	560
2021 Q4	$2.42M	Hold	8,333	–	–	0.04%	501
2021 Q3	$2.42M	Buy	+8,333	New	+$2.42M	0.06%	345

Other funds holding XAGE

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CMU

Carnegie Mellon University Pittsburgh, Pennsylvania $64.3M AUM 35.71% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Saba Capital Management's XAGE Position: Q3 2023 in Review

Saba Capital Management sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q3 2023, closing a stake of 4,278 shares — an estimated $1.32M sold.

Saba Capital Management first reported a position in XAGE in Q3 2021 and held it in 8 quarters. The position peaked at $2.54M in Q1 2023. 14 funds tracked by Wall St. Rank hold XAGE as of Q3 2023.

Saba Capital Management reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Saba Capital Management sold 4,278 Longevity Health Holdings, Inc. Common Stock shares in Q3 2023, an estimated $1.32M.
Saba Capital Management first reported a position in Longevity Health Holdings, Inc. Common Stock in Q3 2021 and held it in 8 quarters.
Saba Capital Management's Longevity Health Holdings, Inc. Common Stock position peaked at $2.54M in Q1 2023.
14 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q3 2023.

Based on Saba Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.